The Biomedical Sciences (BMS) industry was identified as the fourth pillar of Singapore’s economy in 2000. To date, Singapore has become a hub in Asia for cutting research in BMS as well as for development of biotechnology & medical technology products. The manufacturing of pharmaceuticals, biotechnology & medical technology products by more than 100 companies exceed S$30 billion each year; more than 20,000 people are employed in the BMS industry.
With that BioSingapore and BioPharma Asia Convention 2015 are proud to present the first TotalBioPharma meet up in Singapore!
Date : 9 February
Time : 6pm – 9pm
Venue : Creation @ A*STAR, Matrix Bldg, Level 4
Hear from our experts and key speaker, Dr Ong Siew Hwa, CEO of Acumen Research Laboratories, council member of BioSingapore and Singapore Manufacturing Federation as she covers the Singapore’s BMS landscape through
> Areas of therapeutic focuses (technologies & diseases)
> Development of companies (MNCs & SMEs)
> Ecosystem of services (regulatory, standards, clinical trials, IP management & technology transfer processes etc)
> Human capital
> Markets trends and outlooks
> Investments & Capital Access etc.
For more information, contact Kenneth Lai at email@example.com
What else is in store for the rest of the Asia Pacific regions? Learn all this and more through the BioPharma Asia Convention conference agenda discussions!
See you on 9 February!